Integrated biological-behavioural surveillance in pandemic-threat warning systems;Surveillance biologico-comportementale intégrée dans les systèmes d’alerte de menaces pandémiques;Vigilancia integrada de datos biológicos y del comportamiento en sistemas de aviso de amenazas de pandemia

Bulletin of the World Health Organization

Volumn 95, Issue 1, 2017, Pages 62-68

  Miller, Maureen ^a   Hagan, Emily ^b  

^a Department of Medicine   (United States)

^b ECOHEALTH ALLIANCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL SURVEY; BIOMONITORING; DISEASE SPREAD; EPIDEMIOLOGY; HEALTH RISK; HEALTH SURVEY; HUMAN IMMUNODEFICIENCY VIRUS; INTEGRATED APPROACH; POLICY APPROACH; RISK FACTOR; VIRUS; WARNING SYSTEM;

AFRICA; ARTICLE; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; EXPOSURE VARIABLE; FEVER; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; INTEGRATED HEALTH CARE SYSTEM; INTRAVENOUS DRUG ABUSE; NIPAH VIRUS INFECTION; NONHUMAN; PANDEMIC; POLITICS; POVERTY; PREDICTION AND FORECASTING; PROPHYLAXIS; PUBLIC HEALTH SERVICE; RESPIRATORY TRACT INFECTION; SEROLOGY; UNITED STATES; VIRUS DETECTION; VIRUS INFECTION; ZOONOSIS; ANIMAL; COMMUNICABLE DISEASE; HIGH RISK BEHAVIOR; PROCEDURES; RISK MANAGEMENT; TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS;

ANIMALS; COMMUNICABLE DISEASES, EMERGING; HEALTH RISK BEHAVIORS; HUMANS; PANDEMICS; POPULATION SURVEILLANCE; RISK MANAGEMENT; SEROLOGIC TESTS; ZOONOSES;

EID: 85008350832     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.16.175984     Document Type: Article

References (55)

1. Gostin LO. Reforming the World Health Organization after Ebola. JAMA. 2015 Apr 14;313(14):1407-8. doi: http://dx.doi.org/10.1001/jama.2015.2334 PMID:25871658
2. Butler D. How to beat the next Ebola. Nature. 2015 Aug 6;524(7563):22-5. doi: http://dx.doi.org/10.1038/524022a PMID:26245563
3. Lieberman JI, Ridge TJ, Shalala DE, Daschle TA, Greenwood JC, Wainstein KL, et al. A national blueprint for biodefense: leadership and major reforms needed to opitimize efforts report. Bipartisan report of the Blue Ribbon Study Panel on Biodefense. October 2015. Washington: Blue Ribbon Study Panel on Biodefense; 2015.
4. Miller M. Integrating behavioral surveillance into emerging infectious disease prevention. Trans R Soc Trop Med Hyg. 2015 Nov;109(11):673-5. doi: http://dx.doi.org/10.1093/trstmh/trv080 PMID:26464229
5. Marí Saéz A, Weiss S, Nowak K, Lapeyre V, Zimmermann F, Düx A, et al. Investigating the zoonotic origin of the West African Ebola epidemic. EMBO Mol Med. 2015 Jan;7(1):17-23. doi: http://dx.doi.org/10.15252/emmm.201404792 PMID:25550396
6. Victory KR, Coronado F, Ifono SO, Soropogui T, Dahl BA; Centers for Disease Control and Prevention (CDC). Ebola transmission linked to a single traditional funeral ceremony-Kissidougou, Guinea, December, 2014-January 2015. MMWR Morb Mortal Wkly Rep. 2015 Apr 17;64(14):386-8. PMID:25879897
7. Morabia A. From disease surveillance to the surveillance of risk factors. Am J Public Health. 1996 May;86(5):625-7. doi: http://dx.doi.org/10.2105/AJPH.86.5.625 PMID:8629708
8. Masur H, Michelis MA, Greene JB, Onorato I, Stouwe RA, Holzman RS, et al. An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med. 1981 Dec 10;305(24):1431-8. doi: http://dx.doi.org/10.1056/NEJM198112103052402 PMID:6975437
9. Ward MC. A different disease: HIV/AIDS and health care for women in poverty. Cult Med Psychiatry. 1993 Dec;17(4):413-30. doi: http://dx.doi.org/10.1007/BF01379308 PMID:8112085
10. Integrated biological and behavioral surveillance of key populations, toolkit for implementation. Washington: National Alliance of State & Territorial AIDS Directors (NASTAD); 2014. Available from: http://www.nastad.org/sites/default/files/Biological_and_Behavioral_Surveillance:Toolkit_Final_2014.pdf [cited 2016 Mar 9].
11. Integrated Behavioral and Biological Assessment (IBBA). Guidelines for surveys of populations at risk for HIV infection. New Delhi: FHI 360; 2011. Available from: http://www.fhi360.org/sites/default/files/media/documents/Integrated%20Behavioral%20and%20Biological%20Assessment%20Guidelines%20for%20Surveys%20of%20Populations%20at%20Risk%20of%20HIV%20Infection.pdf [cited 2016 Mar 9].
12. Wawer MJ, Makumbi F, Kigozi G, Serwadda D, Watya S, Nalugoda F, et al. Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial. Lancet. 2009 Jul 18;374(9685):229-37. doi: http://dx.doi.org/10.1016/S0140-6736(09)60998-3 PMID:19616720
13. Rehle T, Lazzari S, Dallabetta G, Asamoah-Odei E. Second-generation HIV surveillance: better data for decision-making. Bull World Health Organ. 2004 Feb;82(2):121-7. PMID:15042234
14. Taylor LH, Latham SM, Woolhouse ME. Risk factors for human disease emergence. Philos Trans R Soc Lond B Biol Sci. 2001 Jul 29;356(1411):983-9. doi: http://dx.doi.org/10.1098/rstb.2001.0888 PMID:11516376
15. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, et al. Global trends in emerging infectious diseases. Nature. 2008 Feb 21;451(7181):990-3. doi: http://dx.doi.org/10.1038/nature06536 PMID:18288193
16. Raj VS, Osterhaus AD, Fouchier RA, Haagmans BL. MERS: emergence of a novel human coronavirus. Curr Opin Virol. 2014 Apr;5:58-62. doi: http://dx.doi.org/10.1016/j.coviro.2014.01.010 PMID:24584035
17. Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med. 2013 May 16;368(20):1888-97. doi: http://dx.doi.org/10.1056/NEJMoa1304459 PMID:23577628
18. Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science. 2003 Oct 10;302(5643):276-8. doi: http://dx.doi.org/10.1126/science.1087139 PMID:12958366
19. Pike J, Bogich T, Elwood S, Finnoff DC, Daszak P. Economic optimization of a global strategy to address the pandemic threat. Proc Natl Acad Sci USA. 2014 Dec 30;111(52):18519-23. doi: http://dx.doi.org/10.1073/pnas.1412661112 PMID:25512538
20. Wolfe ND, Dunavan CP, Diamond J. Origins of major human infectious diseases. Nature. 2007 May 17;447(7142):279-83. doi: http://dx.doi.org/10.1038/nature05775 PMID:17507975
21. Karesh WB, Dobson A, Lloyd-Smith JO, Lubroth J, Dixon MA, Bennett M, et al. Ecology of zoonoses: natural and unnatural histories. Lancet. 2012 Dec 1;380(9857):1936-45. doi: http://dx.doi.org/10.1016/S0140-6736(12)61678-X PMID:23200502
22. Murray KA, Preston N, Allen T, Zambrana-Torrelio C, Hosseini PR, Daszak P. Global biogeography of human infectious diseases. Proc Natl Acad Sci USA. 2015 Oct 13;112(41):12746-51. doi: http://dx.doi.org/10.1073/pnas.1507442112 PMID:26417098
23. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014 Dec;12(12):1495-9. doi: http://dx.doi.org/10.1016/j.ijsu.2014.07.013 PMID:25046131
24. Wolfe ND, Daszak P, Kilpatrick AM, Burke DS. Bushmeat hunting, deforestation, and prediction of zoonoses emergence. Emerg Infect Dis. 2005 Dec;11(12):1822-7. doi: http://dx.doi.org/10.3201/eid1112.040789 PMID:16485465
25. Wolfe ND, Switzer WM, Carr JK, Bhullar VB, Shanmugam V, Tamoufe U, et al. Naturally acquired simian retrovirus infections in central African hunters. Lancet. 2004 Mar 20;363(9413):932-7. doi: http://dx.doi.org/10.1016/S0140-6736(04)15787-5 PMID:15043960
26. Mouinga-Ondémé A, Caron M, Nkoghé D, Telfer P, Marx P, Saïb A, et al. Cross-species transmission of simian foamy virus to humans in rural Gabon, Central Africa. J Virol. 2012 Jan;86(2):1255-60. doi: http://dx.doi.org/10.1128/JVI.06016-11 PMID:22072747
27. Luby SP, Gurley ES, Hossain MJ. Transmission of human infection with Nipah virus. Clin Infect Dis. 2009 Dec 1;49(11):1743-8. doi: http://dx.doi.org/10.1086/647951 PMID:19886791
28. Mills JN, Corneli A, Young JC, Garrison LE, Khan AS, Ksiazek TG; Centers for Disease Control and Prevention. Hantavirus pulmonary syndrome-United States: updated recommendations for risk reduction. MMWR Recomm Rep. 2002 Jul 26;51(RR-9):1-12. PMID:12194506
29. Centers for Disease Control and Prevention. Update: outbreak of severe acute respiratory syndrome-worldwide, 2003. MMWR Morb Mortal Wkly Rep. 2003 Apr 4;52(13):269-72. PMID:12729074
30. WHO surveillance case definitions for ILI and SARI [Internet]. Geneva: World Health Organization; 2014. Available from: http://www.who.int/influenza/surveillance:monitoring/ili_sari_surveillance:case_definition/en/ [cited 2016 Feb 24].
31. Venkatesan A, Tunkel AR, Bloch KC, Lauring AS, Sejvar J, Bitnun A, et al.; International Encephalitis Consortium. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis. 2013 Oct;57(8):1114-28. doi: http://dx.doi.org/10.1093/cid/cit458 PMID:23861361
32. Chan-Tack KM, Bartlett J. Fever of unknown origin. [Internet]. New York: Medscape; 2015. Available from: http://emedicine.medscape.com/article/217675-overview [cited 2016 Oct 17].
33. Viral hemorrhagic fever (VHF). 2010 case definition [Internet]. Atlanta: Centers for Disease Control and Prevention; 2010. Available from: https:// wwwn.cdc.gov/nndss/conditions/viral-hemorrhagic-fever/casedefinition/ 2010/ [cited 2016 Oct 17].
34. Berkman LF, Kawachi I, Glymour MM, editors. Social epidemiology. Oxford: Oxford University Press; 2014. doi: http://dx.doi.org/10.1093/med/9780195377903.001.0001
35. Childs JE, Glass GE, Ksiazek TG, Rossi CA, Oro JG, Leduc JW. Human-rodent contact and infection with lymphocytic choriomeningitis and Seoul viruses in an inner-city population. Am J Trop Med Hyg. 1991 Feb;44(2):117-21. PMID:1672798
36. Suwannarong K, Chapman RS. Characteristics associated with contact with rodents in, around, and outside homes in Khon Kaen province, Thailand. Am J Trop Med Hyg. 2015 Apr;92(4):784-90. doi: http://dx.doi.org/10.4269/ajtmh.14-0195 PMID:25646260
37. Middle East respiratory syndrome (MERS) in the Republic of Korea; situation assessment, 15 June 2015. Geneva: World Health Organization; 2015. Available from: http://www.who.int/csr/disease/coronavirus_infections/situation-assessment/update-15-06-2015/en/ [cited 2016 Feb 25].
38. Becquart P, Wauquier N, Mahlakõiv T, Nkoghe D, Padilla C, Souris M, et al. High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon. PLoS ONE. 2010;5(2):e9126. doi: http://dx.doi.org/10.1371/journal.pone.0009126 PMID:20161740
39. Blackburn NK, Searle L, Taylor P. Viral haemorrhagic fever antibodies in Zimbabwe schoolchildren. Trans R Soc Trop Med Hyg. 1982;76(6):803-5. doi: http://dx.doi.org/10.1016/0035-9203(82)90113-4 PMID:6761909
40. Gonzalez J-P, Josse R, Johnson ED, Merlin M, Georges AJ, Abandja J, et al. Antibody prevalence against haemorrhagic fever viruses in randomized representative Central African populations. Res Virol. 1989 Jul-Aug;140(4):319-31. doi: http://dx.doi.org/10.1016/S0923-2516(89)80112-8 PMID:2505350
41. Gonzalez JP, McCormick JB, Saluzzo JF, Georges AJ. African haemorrhagic fevers of viral origin. Contribution to their study in Central African Republic. Cah ORSTOM. Sér Entom Méd Parasitol. 1983;21(2):119-30. French.
42. Gonzalez JP, Nakoune E, Slenczka W, Vidal P, Morvan JM. Ebola and Marburg virus antibody prevalence in selected populations of the Central African Republic. Microbes Infect. 2000 Jan;2(1):39-44. doi: http://dx.doi.org/10.1016/S1286-4579(00)00287-2 PMID:10717539
43. Ivanoff B, Duquesnoy P, Languillat G, Saluzzo JF, Georges A, Gonzalez JP, et al. Haemorrhagic fever in Gabon. I. Incidence of Lassa, Ebola and Marburg viruses in Haut-Ogooué. Trans R Soc Trop Med Hyg. 1982;76(6):719-20. doi: http://dx.doi.org/10.1016/0035-9203(82)90089-X PMID:7164137
44. Johnson ED, Gonzalez J-P, Georges A. Haemorrhagic fever virus activity in equatorial Africa: distribution and prevalence of filovirus reactive antibody in the Central African Republic. Trans R Soc Trop Med Hyg. 1993 Sep-Oct;87(5):530-5. doi: http://dx.doi.org/10.1016/0035-9203(93)90075-2 PMID:8266402
45. Johnson ED, Gonzalez J-P, Georges A. Filovirus activity among selected ethnic groups inhabiting the tropical forest of equatorial Africa. Trans R Soc Trop Med Hyg. 1993 Sep-Oct;87(5):536-8. doi: http://dx.doi.org/10.1016/0035-9203(93)90077-4 PMID:8266403
46. Knobloch J, Albiez EJ, Schmitz H. A serological survey on viral hemorrhagic fevers in Liberia. Ann Inst Pasteur Virol. 1982 Dec;133(2):125-8. doi: http://dx.doi.org/10.1016/S0769-2617(82)80028-2
47. Mathiot CC, Fontenille D, Georges AJ, Coulanges P. Antibodies to haemorrhagic fever viruses in Madagascar populations. Trans R Soc Trop Med Hyg. 1989 May-Jun;83(3):407-9. doi: http://dx.doi.org/10.1016/0035-9203(89)90519-1 PMID:2515626
48. Nakounné E, Selekon B, Morvan J. Veille microbiologique: les fièvres hémorragiques virales en République centrafricaine; données sérologiques actualisées chez l’homme. Bull Soc Pathol Exot. 2000 Jan;93(5):340-7. PMID:11775321
49. Pernet O, Schneider BS, Beaty SM, LeBreton M, Yun TE, Park A, et al. Evidence for henipavirus spillover into human populations in Africa. Nat Commun. 2014 Nov 18;5:5342. doi: http://dx.doi.org/10.1038/ncomms6342 PMID:25405640
50. Outbreaks chronology: Ebola virus disease [Internet]. Atlanta: Centers for Disease Control and Prevention; 2015. Available from: http://www.cdc.gov/vhf/ebola/outbreaks/history/chronology.html [cited 2016 Feb 26].
51. Xu GJ, Kula T, Xu Q, Li MZ, Vernon SD, Ndung’u T, et al. Viral immunology. Comprehensive serological profiling of human populations using a synthetic human virome. Science. 2015 Jun 5;348(6239):aaa0698. doi: http://dx.doi.org/10.1126/science.aaa0698 PMID:26045439
52. Schwenk JM, Lindberg J, Sundberg M, Uhlén M, Nilsson P. Determination of binding specificities in highly multiplexed bead-based assays for antibody proteomics. Mol Cell Proteomics. 2007 Jan;6(1):125-32. doi: http://dx.doi.org/10.1074/mcp.T600035-MCP200 PMID:17060675
53. Global report: UNAIDS report on the global AIDS epidemic, 2013. Geneva: Joint United Nations Programme on HIV/AIDS; 2013. Available from: http://www.unaids.org/sites/default/files/media_asset/UNAIDS_Global_Report_2013_en_1.pdf [cited 2016 Mar 8].
54. Herbst K, Law M, Geldsetzer P, Tanser F, Harling G, Bärnighausen T. Innovations in health and demographic surveillance systems to establish the causal impacts of HIV policies. Curr Opin HIV AIDS. 2015 Nov;10(6):483-94. doi: http://dx.doi.org/10.1097/COH.0000000000000203 PMID:26371462
55. Jose B, Friedman SR, Neaigus A, Curtis R, Grund J-PC, Goldstein MF, et al. Syringe-mediated drug-sharing (backloading): a new risk factor for HIV among injecting drug users. AIDS. 1993 Dec;7(12):1653-60. doi: http://dx.doi.org/10.1097/00002030-199312000-00017 PMID:8286076